INTERNATIONAL IMMUNOPHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2110804, encodeId=00bc211080466, content=接收了一个月，还没proof这个是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=600b8147014, createdName=ms3000001044911434, createdTime=Thu Jan 19 02:30:29 CST 2023, time=2023-01-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2110220, encodeId=778a211022082, content=With Editor 8天了，而且状态时间也没变，这是怎么回事额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Sat Jan 14 19:31:26 CST 2023, time=2023-01-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109011, encodeId=06e921090117a, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：感觉好难，要求好严格，让补充很多实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=59c25516259, createdName=ms4000001901470419, createdTime=Fri Jan 06 02:42:50 CST 2023, time=2023-01-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2104037, encodeId=58c1210403e2a, content=姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Dec 03 03:50:21 CST 2022, time=2022-12-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2107129, encodeId=2de2210e12952, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理学;炎症 经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28be5692038, createdName=ms9000000971579239, createdTime=Fri Dec 23 10:22:17 CST 2022, time=2022-12-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228571, encodeId=828712285e1cc, content=偏重的研究方向：药理学;炎症 经验分享：6月24号submit 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=68345397047, createdName=ms9000000418821437, createdTime=Sat Jun 25 10:21:14 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106063, encodeId=f211210606365, content=大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Wed Dec 14 20:32:01 CST 2022, time=2022-12-14, status=1, ipAttribution=法兰克福), GetPortalCommentsPageByObjectIdResponse(id=2100630, encodeId=956a2100630e2, content=投稿第二天decision in prossess 是要直接拒的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Tue Nov 15 11:22:02 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093874, encodeId=85b820938e4cb, content=投稿第二天decision in process，是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/364c7d1735f6efe3571e00ec859f9f67.jpg, createdBy=4a492102836, createdName=anne1001, createdTime=Sat Oct 15 07:09:56 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103131, encodeId=46f72103131d2, content=这个杂志为什么注册不了，填完所有信息后界面仍无反应？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18a52333787, createdName=12276bdam91(暂无昵称), createdTime=Mon Nov 28 18:58:50 CST 2022, time=2022-11-28, status=1, ipAttribution=北京)]

2023-01-19 ms3000001044911434 来自广西

接收了一个月，还没proof这个是怎么回事呀

53 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110804, encodeId=00bc211080466, content=接收了一个月，还没proof这个是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=600b8147014, createdName=ms3000001044911434, createdTime=Thu Jan 19 02:30:29 CST 2023, time=2023-01-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2110220, encodeId=778a211022082, content=With Editor 8天了，而且状态时间也没变，这是怎么回事额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Sat Jan 14 19:31:26 CST 2023, time=2023-01-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109011, encodeId=06e921090117a, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：感觉好难，要求好严格，让补充很多实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=59c25516259, createdName=ms4000001901470419, createdTime=Fri Jan 06 02:42:50 CST 2023, time=2023-01-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2104037, encodeId=58c1210403e2a, content=姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Dec 03 03:50:21 CST 2022, time=2022-12-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2107129, encodeId=2de2210e12952, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理学;炎症 经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28be5692038, createdName=ms9000000971579239, createdTime=Fri Dec 23 10:22:17 CST 2022, time=2022-12-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228571, encodeId=828712285e1cc, content=偏重的研究方向：药理学;炎症 经验分享：6月24号submit 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=68345397047, createdName=ms9000000418821437, createdTime=Sat Jun 25 10:21:14 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106063, encodeId=f211210606365, content=大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Wed Dec 14 20:32:01 CST 2022, time=2022-12-14, status=1, ipAttribution=法兰克福), GetPortalCommentsPageByObjectIdResponse(id=2100630, encodeId=956a2100630e2, content=投稿第二天decision in prossess 是要直接拒的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Tue Nov 15 11:22:02 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093874, encodeId=85b820938e4cb, content=投稿第二天decision in process，是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/364c7d1735f6efe3571e00ec859f9f67.jpg, createdBy=4a492102836, createdName=anne1001, createdTime=Sat Oct 15 07:09:56 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103131, encodeId=46f72103131d2, content=这个杂志为什么注册不了，填完所有信息后界面仍无反应？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18a52333787, createdName=12276bdam91(暂无昵称), createdTime=Mon Nov 28 18:58:50 CST 2022, time=2022-11-28, status=1, ipAttribution=北京)]

2023-01-14 ms2000001187604097 来自湖南省

With Editor 8天了，而且状态时间也没变，这是怎么回事额

32 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110804, encodeId=00bc211080466, content=接收了一个月，还没proof这个是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=600b8147014, createdName=ms3000001044911434, createdTime=Thu Jan 19 02:30:29 CST 2023, time=2023-01-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2110220, encodeId=778a211022082, content=With Editor 8天了，而且状态时间也没变，这是怎么回事额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Sat Jan 14 19:31:26 CST 2023, time=2023-01-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109011, encodeId=06e921090117a, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：感觉好难，要求好严格，让补充很多实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=59c25516259, createdName=ms4000001901470419, createdTime=Fri Jan 06 02:42:50 CST 2023, time=2023-01-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2104037, encodeId=58c1210403e2a, content=姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Dec 03 03:50:21 CST 2022, time=2022-12-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2107129, encodeId=2de2210e12952, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理学;炎症 经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28be5692038, createdName=ms9000000971579239, createdTime=Fri Dec 23 10:22:17 CST 2022, time=2022-12-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228571, encodeId=828712285e1cc, content=偏重的研究方向：药理学;炎症 经验分享：6月24号submit 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=68345397047, createdName=ms9000000418821437, createdTime=Sat Jun 25 10:21:14 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106063, encodeId=f211210606365, content=大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Wed Dec 14 20:32:01 CST 2022, time=2022-12-14, status=1, ipAttribution=法兰克福), GetPortalCommentsPageByObjectIdResponse(id=2100630, encodeId=956a2100630e2, content=投稿第二天decision in prossess 是要直接拒的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Tue Nov 15 11:22:02 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093874, encodeId=85b820938e4cb, content=投稿第二天decision in process，是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/364c7d1735f6efe3571e00ec859f9f67.jpg, createdBy=4a492102836, createdName=anne1001, createdTime=Sat Oct 15 07:09:56 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103131, encodeId=46f72103131d2, content=这个杂志为什么注册不了，填完所有信息后界面仍无反应？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18a52333787, createdName=12276bdam91(暂无昵称), createdTime=Mon Nov 28 18:58:50 CST 2022, time=2022-11-28, status=1, ipAttribution=北京)]

2023-01-06 ms4000001901470419 来自江苏省

审稿速度:2.0 | 投稿命中率:75.0
经验分享：感觉好难，要求好严格，让补充很多实验

25 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110804, encodeId=00bc211080466, content=接收了一个月，还没proof这个是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=600b8147014, createdName=ms3000001044911434, createdTime=Thu Jan 19 02:30:29 CST 2023, time=2023-01-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2110220, encodeId=778a211022082, content=With Editor 8天了，而且状态时间也没变，这是怎么回事额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Sat Jan 14 19:31:26 CST 2023, time=2023-01-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109011, encodeId=06e921090117a, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：感觉好难，要求好严格，让补充很多实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=59c25516259, createdName=ms4000001901470419, createdTime=Fri Jan 06 02:42:50 CST 2023, time=2023-01-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2104037, encodeId=58c1210403e2a, content=姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Dec 03 03:50:21 CST 2022, time=2022-12-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2107129, encodeId=2de2210e12952, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理学;炎症 经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28be5692038, createdName=ms9000000971579239, createdTime=Fri Dec 23 10:22:17 CST 2022, time=2022-12-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228571, encodeId=828712285e1cc, content=偏重的研究方向：药理学;炎症 经验分享：6月24号submit 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=68345397047, createdName=ms9000000418821437, createdTime=Sat Jun 25 10:21:14 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106063, encodeId=f211210606365, content=大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Wed Dec 14 20:32:01 CST 2022, time=2022-12-14, status=1, ipAttribution=法兰克福), GetPortalCommentsPageByObjectIdResponse(id=2100630, encodeId=956a2100630e2, content=投稿第二天decision in prossess 是要直接拒的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Tue Nov 15 11:22:02 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093874, encodeId=85b820938e4cb, content=投稿第二天decision in process，是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/364c7d1735f6efe3571e00ec859f9f67.jpg, createdBy=4a492102836, createdName=anne1001, createdTime=Sat Oct 15 07:09:56 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103131, encodeId=46f72103131d2, content=这个杂志为什么注册不了，填完所有信息后界面仍无反应？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18a52333787, createdName=12276bdam91(暂无昵称), createdTime=Mon Nov 28 18:58:50 CST 2022, time=2022-11-28, status=1, ipAttribution=北京)]

2022-12-03 小甜甜66 来自湖北省

姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？

36 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110804, encodeId=00bc211080466, content=接收了一个月，还没proof这个是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=600b8147014, createdName=ms3000001044911434, createdTime=Thu Jan 19 02:30:29 CST 2023, time=2023-01-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2110220, encodeId=778a211022082, content=With Editor 8天了，而且状态时间也没变，这是怎么回事额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Sat Jan 14 19:31:26 CST 2023, time=2023-01-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109011, encodeId=06e921090117a, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：感觉好难，要求好严格，让补充很多实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=59c25516259, createdName=ms4000001901470419, createdTime=Fri Jan 06 02:42:50 CST 2023, time=2023-01-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2104037, encodeId=58c1210403e2a, content=姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Dec 03 03:50:21 CST 2022, time=2022-12-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2107129, encodeId=2de2210e12952, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理学;炎症 经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28be5692038, createdName=ms9000000971579239, createdTime=Fri Dec 23 10:22:17 CST 2022, time=2022-12-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228571, encodeId=828712285e1cc, content=偏重的研究方向：药理学;炎症 经验分享：6月24号submit 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=68345397047, createdName=ms9000000418821437, createdTime=Sat Jun 25 10:21:14 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106063, encodeId=f211210606365, content=大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Wed Dec 14 20:32:01 CST 2022, time=2022-12-14, status=1, ipAttribution=法兰克福), GetPortalCommentsPageByObjectIdResponse(id=2100630, encodeId=956a2100630e2, content=投稿第二天decision in prossess 是要直接拒的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Tue Nov 15 11:22:02 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093874, encodeId=85b820938e4cb, content=投稿第二天decision in process，是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/364c7d1735f6efe3571e00ec859f9f67.jpg, createdBy=4a492102836, createdName=anne1001, createdTime=Sat Oct 15 07:09:56 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103131, encodeId=46f72103131d2, content=这个杂志为什么注册不了，填完所有信息后界面仍无反应？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18a52333787, createdName=12276bdam91(暂无昵称), createdTime=Mon Nov 28 18:58:50 CST 2022, time=2022-11-28, status=1, ipAttribution=北京)]

2022-12-23 ms9000000971579239 来自湖北省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：药理学;炎症
经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。

30 0

[GetPortalCommentsPageByObjectIdResponse(id=2110804, encodeId=00bc211080466, content=接收了一个月，还没proof这个是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=600b8147014, createdName=ms3000001044911434, createdTime=Thu Jan 19 02:30:29 CST 2023, time=2023-01-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2110220, encodeId=778a211022082, content=With Editor 8天了，而且状态时间也没变，这是怎么回事额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Sat Jan 14 19:31:26 CST 2023, time=2023-01-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109011, encodeId=06e921090117a, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：感觉好难，要求好严格，让补充很多实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=59c25516259, createdName=ms4000001901470419, createdTime=Fri Jan 06 02:42:50 CST 2023, time=2023-01-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2104037, encodeId=58c1210403e2a, content=姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Dec 03 03:50:21 CST 2022, time=2022-12-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2107129, encodeId=2de2210e12952, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理学;炎症 经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28be5692038, createdName=ms9000000971579239, createdTime=Fri Dec 23 10:22:17 CST 2022, time=2022-12-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228571, encodeId=828712285e1cc, content=偏重的研究方向：药理学;炎症 经验分享：6月24号submit 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=68345397047, createdName=ms9000000418821437, createdTime=Sat Jun 25 10:21:14 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106063, encodeId=f211210606365, content=大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Wed Dec 14 20:32:01 CST 2022, time=2022-12-14, status=1, ipAttribution=法兰克福), GetPortalCommentsPageByObjectIdResponse(id=2100630, encodeId=956a2100630e2, content=投稿第二天decision in prossess 是要直接拒的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Tue Nov 15 11:22:02 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093874, encodeId=85b820938e4cb, content=投稿第二天decision in process，是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/364c7d1735f6efe3571e00ec859f9f67.jpg, createdBy=4a492102836, createdName=anne1001, createdTime=Sat Oct 15 07:09:56 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103131, encodeId=46f72103131d2, content=这个杂志为什么注册不了，填完所有信息后界面仍无反应？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18a52333787, createdName=12276bdam91(暂无昵称), createdTime=Mon Nov 28 18:58:50 CST 2022, time=2022-11-28, status=1, ipAttribution=北京)]

2022-06-25 ms9000000418821437

偏重的研究方向：药理学;炎症
经验分享：6月24号submit 记录一下

451 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110804, encodeId=00bc211080466, content=接收了一个月，还没proof这个是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=600b8147014, createdName=ms3000001044911434, createdTime=Thu Jan 19 02:30:29 CST 2023, time=2023-01-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2110220, encodeId=778a211022082, content=With Editor 8天了，而且状态时间也没变，这是怎么回事额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Sat Jan 14 19:31:26 CST 2023, time=2023-01-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109011, encodeId=06e921090117a, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：感觉好难，要求好严格，让补充很多实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=59c25516259, createdName=ms4000001901470419, createdTime=Fri Jan 06 02:42:50 CST 2023, time=2023-01-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2104037, encodeId=58c1210403e2a, content=姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Dec 03 03:50:21 CST 2022, time=2022-12-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2107129, encodeId=2de2210e12952, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理学;炎症 经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28be5692038, createdName=ms9000000971579239, createdTime=Fri Dec 23 10:22:17 CST 2022, time=2022-12-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228571, encodeId=828712285e1cc, content=偏重的研究方向：药理学;炎症 经验分享：6月24号submit 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=68345397047, createdName=ms9000000418821437, createdTime=Sat Jun 25 10:21:14 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106063, encodeId=f211210606365, content=大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Wed Dec 14 20:32:01 CST 2022, time=2022-12-14, status=1, ipAttribution=法兰克福), GetPortalCommentsPageByObjectIdResponse(id=2100630, encodeId=956a2100630e2, content=投稿第二天decision in prossess 是要直接拒的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Tue Nov 15 11:22:02 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093874, encodeId=85b820938e4cb, content=投稿第二天decision in process，是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/364c7d1735f6efe3571e00ec859f9f67.jpg, createdBy=4a492102836, createdName=anne1001, createdTime=Sat Oct 15 07:09:56 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103131, encodeId=46f72103131d2, content=这个杂志为什么注册不了，填完所有信息后界面仍无反应？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18a52333787, createdName=12276bdam91(暂无昵称), createdTime=Mon Nov 28 18:58:50 CST 2022, time=2022-11-28, status=1, ipAttribution=北京)]

2022-12-14 ms3000000631272663 来自法兰克福

大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2110804, encodeId=00bc211080466, content=接收了一个月，还没proof这个是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=600b8147014, createdName=ms3000001044911434, createdTime=Thu Jan 19 02:30:29 CST 2023, time=2023-01-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2110220, encodeId=778a211022082, content=With Editor 8天了，而且状态时间也没变，这是怎么回事额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Sat Jan 14 19:31:26 CST 2023, time=2023-01-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109011, encodeId=06e921090117a, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：感觉好难，要求好严格，让补充很多实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=59c25516259, createdName=ms4000001901470419, createdTime=Fri Jan 06 02:42:50 CST 2023, time=2023-01-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2104037, encodeId=58c1210403e2a, content=姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Dec 03 03:50:21 CST 2022, time=2022-12-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2107129, encodeId=2de2210e12952, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理学;炎症 经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28be5692038, createdName=ms9000000971579239, createdTime=Fri Dec 23 10:22:17 CST 2022, time=2022-12-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228571, encodeId=828712285e1cc, content=偏重的研究方向：药理学;炎症 经验分享：6月24号submit 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=68345397047, createdName=ms9000000418821437, createdTime=Sat Jun 25 10:21:14 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106063, encodeId=f211210606365, content=大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Wed Dec 14 20:32:01 CST 2022, time=2022-12-14, status=1, ipAttribution=法兰克福), GetPortalCommentsPageByObjectIdResponse(id=2100630, encodeId=956a2100630e2, content=投稿第二天decision in prossess 是要直接拒的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Tue Nov 15 11:22:02 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093874, encodeId=85b820938e4cb, content=投稿第二天decision in process，是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/364c7d1735f6efe3571e00ec859f9f67.jpg, createdBy=4a492102836, createdName=anne1001, createdTime=Sat Oct 15 07:09:56 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103131, encodeId=46f72103131d2, content=这个杂志为什么注册不了，填完所有信息后界面仍无反应？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18a52333787, createdName=12276bdam91(暂无昵称), createdTime=Mon Nov 28 18:58:50 CST 2022, time=2022-11-28, status=1, ipAttribution=北京)]

2022-11-15 ms8000002098041036

投稿第二天decision in prossess 是要直接拒的意思吗

26 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110804, encodeId=00bc211080466, content=接收了一个月，还没proof这个是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=600b8147014, createdName=ms3000001044911434, createdTime=Thu Jan 19 02:30:29 CST 2023, time=2023-01-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2110220, encodeId=778a211022082, content=With Editor 8天了，而且状态时间也没变，这是怎么回事额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Sat Jan 14 19:31:26 CST 2023, time=2023-01-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109011, encodeId=06e921090117a, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：感觉好难，要求好严格，让补充很多实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=59c25516259, createdName=ms4000001901470419, createdTime=Fri Jan 06 02:42:50 CST 2023, time=2023-01-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2104037, encodeId=58c1210403e2a, content=姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Dec 03 03:50:21 CST 2022, time=2022-12-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2107129, encodeId=2de2210e12952, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理学;炎症 经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28be5692038, createdName=ms9000000971579239, createdTime=Fri Dec 23 10:22:17 CST 2022, time=2022-12-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228571, encodeId=828712285e1cc, content=偏重的研究方向：药理学;炎症 经验分享：6月24号submit 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=68345397047, createdName=ms9000000418821437, createdTime=Sat Jun 25 10:21:14 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106063, encodeId=f211210606365, content=大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Wed Dec 14 20:32:01 CST 2022, time=2022-12-14, status=1, ipAttribution=法兰克福), GetPortalCommentsPageByObjectIdResponse(id=2100630, encodeId=956a2100630e2, content=投稿第二天decision in prossess 是要直接拒的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Tue Nov 15 11:22:02 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093874, encodeId=85b820938e4cb, content=投稿第二天decision in process，是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/364c7d1735f6efe3571e00ec859f9f67.jpg, createdBy=4a492102836, createdName=anne1001, createdTime=Sat Oct 15 07:09:56 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103131, encodeId=46f72103131d2, content=这个杂志为什么注册不了，填完所有信息后界面仍无反应？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18a52333787, createdName=12276bdam91(暂无昵称), createdTime=Mon Nov 28 18:58:50 CST 2022, time=2022-11-28, status=1, ipAttribution=北京)]

2022-10-15 anne1001

投稿第二天decision in process，是不是要悲剧

42 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2110804, encodeId=00bc211080466, content=接收了一个月，还没proof这个是怎么回事呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=600b8147014, createdName=ms3000001044911434, createdTime=Thu Jan 19 02:30:29 CST 2023, time=2023-01-19, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2110220, encodeId=778a211022082, content=With Editor 8天了，而且状态时间也没变，这是怎么回事额, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d63e8115811, createdName=ms2000001187604097, createdTime=Sat Jan 14 19:31:26 CST 2023, time=2023-01-14, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2109011, encodeId=06e921090117a, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：感觉好难，要求好严格，让补充很多实验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=59c25516259, createdName=ms4000001901470419, createdTime=Fri Jan 06 02:42:50 CST 2023, time=2023-01-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2104037, encodeId=58c1210403e2a, content=姐妹们，请问一个m i n o r一个拒，编辑给了大修。。。中的可能性大不大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Dec 03 03:50:21 CST 2022, time=2022-12-03, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2107129, encodeId=2de2210e12952, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理学;炎症 经验分享：8.24投稿 10.17意见返回，大修 12.14修回第二天under review 12.22审稿人审完 12.23接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28be5692038, createdName=ms9000000971579239, createdTime=Fri Dec 23 10:22:17 CST 2022, time=2022-12-23, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1228571, encodeId=828712285e1cc, content=偏重的研究方向：药理学;炎症 经验分享：6月24号submit 记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=68345397047, createdName=ms9000000418821437, createdTime=Sat Jun 25 10:21:14 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106063, encodeId=f211210606365, content=大家好，请问一作投稿后最后跳转到生成pdf由通讯确认后上传是对的吗？？？投其他旗下期刊不是这样，所以想问下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55a08309764, createdName=ms3000000631272663, createdTime=Wed Dec 14 20:32:01 CST 2022, time=2022-12-14, status=1, ipAttribution=法兰克福), GetPortalCommentsPageByObjectIdResponse(id=2100630, encodeId=956a2100630e2, content=投稿第二天decision in prossess 是要直接拒的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eaaa8423268, createdName=ms8000002098041036, createdTime=Tue Nov 15 11:22:02 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2093874, encodeId=85b820938e4cb, content=投稿第二天decision in process，是不是要悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/25/364c7d1735f6efe3571e00ec859f9f67.jpg, createdBy=4a492102836, createdName=anne1001, createdTime=Sat Oct 15 07:09:56 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103131, encodeId=46f72103131d2, content=这个杂志为什么注册不了，填完所有信息后界面仍无反应？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=18a52333787, createdName=12276bdam91(暂无昵称), createdTime=Mon Nov 28 18:58:50 CST 2022, time=2022-11-28, status=1, ipAttribution=北京)]

2022-11-28 12276bdam91(暂无昵称) 来自北京

这个杂志为什么注册不了，填完所有信息后界面仍无反应？

24 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务